3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
3
Unknown
2
Completed
2
Terminated
1
Sponsor Class
OTHER
2
Study Type
Observational
1
Interventional
1
Sponsor
Conditions
Breast Neoplasms
4354
Neoplasms
3055
Prostatic Neoplasms
1904
Colorectal Neoplasms
1738
Lung Neoplasms
1555
Carcinoma, Non-Small-Cell Lung
1270
Pancreatic Neoplasms
981
Multiple Myeloma
951
Leukemia, Myeloid, Acute
951
Lymphoma
912
Head and Neck Neoplasms
894
Leukemia
852
Precursor Cell Lymphoblastic Leukemia-Lymphoma
833
Neoplasm Metastasis
793
Colonic Neoplasms
785
Carcinoma, Hepatocellular
762
Ovarian Neoplasms
757
Melanoma
752
Stomach Neoplasms
740
Rectal Neoplasms
701
Brain Neoplasms
696
Lymphoma, Non-Hodgkin
663
Leukemia, Lymphocytic, Chronic, B-Cell
618
Uterine Cervical Neoplasms
607
Lymphoma, Follicular
559
Glioblastoma
541
Recurrence
539
Hodgkin Disease
532
Esophageal Neoplasms
527
Myelodysplastic Syndromes
508
Interventions
Varenicline
1
Tobacco Use Cessation Devices
1
Nicotine Chewing Gum
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
OTHER
×
Behavior, Addictive
×
Clear all
NCT04634071
2026-02-02
TTOP
University of Kentucky
Phase 2
Completed
126 enrolled
NCT03706937
2019-07-23
PREFACE
Institut de Cancérologie de la Loire
Completed
15 enrolled